DAS181 Single Dose Escalation Study in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 18, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

May 23, 2010

Conditions
Healthy
Interventions
DRUG

DAS181

DAS181 is formulated as dry powder and packaged in capsules containing DAS181. The delivered dose of DAS181 dry powder at each fill size is 5 mg, 10 mg and 20 mg.

DRUG

Lactose

Trial Locations (1)

66211

Quintiles Phase One Services, Overland Park

Sponsors
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Ansun Biopharma, Inc.

INDUSTRY

NCT00876161 - DAS181 Single Dose Escalation Study in Healthy Adults | Biotech Hunter | Biotech Hunter